Amgen bought Ch...
login
Shares
Bonds
π₯Pre-IPO
Dividends
Portfolio
More
ETF
Sectors
News
Calendar
Try for free
Login
×
Email
Password
Forgot your password?
Login
Resend my activation email
Need an account? Sign up.
Home
News
ChemoCentryx
Amgen bought ChemoCentryx
10/20/22 at 16:16
Share at
Vladimir Petenev
News editor
press@blackterminal.com
Amgen completed its acquisition of ChemoCentryx for $3.7 billion, or $52 per share.
ChemoCentryx
Review
Source:
investors.amgen.com
Vladimir Petenev
News editor
Share at:
Share this news
×
To leave a comment, you must be logged in
Write your comment first
News feed
Board of Directors of International Trade Centre recommended that dividends be paid for 2022
3/23/23
WTCM
MTS acquires car electronics manufacturer
3/23/23
MTSS
Raspadskaya is diversifying its sales channels
3/23/23
RASP
Rosseti North Caucasus reported for 2022
3/23/23
MRKK
Moscow Exchange in 2023 expects about 10 IPOs of companies with capitalizations of up to β½10 billion
3/23/23
MOEX
The China Mobile announced a quarterly dividend
3/23/23
941
China Mobile's Profit in 2022 Increased by 8%
3/23/23
941
Polyus may acquire GV Gold's gold processing plants
3/23/23
PLZL
En+ Group increased aluminum production and reduced energy production in 2022
3/23/23
ENPG
Mechel increased sales of long products by 7% in 2022
3/23/23
MTLR
«
Previous
681
682
683
684
685
686
687
688
689
690
»
Next
BlackTerminal.com 2016 - 2025.
English (US)
English (US)
Π ΡΡΡΠΊΠΈΠΉ (Π Π€)